摘要
目的:研究丹酚酸B注射剂的生殖毒性及遗传毒性。方法:生殖毒性方面研究了丹酚酸B注射剂对SD大鼠胚胎-胎仔发育毒性的影响,于SD大鼠妊娠第6~15天分别连续静脉注射给予29、120、480 mg/(kg·d)的丹酚酸B注射剂,于妊娠第20天剖检,分析其生殖毒性。分别采用Ames试验、中国仓鼠肺细胞(CHL)染色体畸变试验、小鼠骨髓微核试验,观察丹酚酸B注射剂的遗传毒性。结果:胚胎-胎仔发育毒性试验中,丹酚酸B注射剂各剂量组的孕鼠均未出现明显毒性反应,中、高剂量的丹酚酸B注射剂会影响胎鼠发育。遗传毒性的Ames试验、CHL试验和微核试验均为阴性。结论:480 mg/(kg·d)及以下剂量的丹酚酸B注射剂对孕鼠无母体毒性作用。29 mg/(kg·d)的丹酚酸B注射剂对胚胎-胎仔发育无毒性;丹酚酸B注射剂未见明显遗传毒性。
Objective: To study the genetic and reproductive toxicity of Salvianolic acid B injection. Methods: The reproductive toxicity study was studied by investigating the effects of Salvianolic acid B injection on embryo-fetal development toxicity in Sprague-Dawley rats. Pregnant rats were administrated Salvianolic acid B injection at the doses of 29 mg/(kg·d), 120 mg/(kg·d) and 480 mg/(kg·d) at GD6-GD15. The rats were sacrificed and examined reproductive toxicity of Salvianolic acid B injection at GD20. The genotoxicity of Salvianolic acid B injection was examined by the Ames test, Chinese hamster lung fibroblast cell chromosome aberration test and mouse bone marrow micronucleus test. Results: In embryo-fetal development toxicity studies, no obvious toxic reactions were observed in pregnant rats at all the doses groups. Salvianolic acid B injection was found to have effect on rats embryonic development in 120 mg/(kg·d) dose group and 480 mg/(kg·d) dose group. The negative genetic toxicity results were obtained in the Ames test, Chinese hamster lung fibroblast cell chromosome aberration test and mouse bone marrow micronucleus test. Conclusion: Salvianolic acid B injection shows no maternal toxicity on Sprague-Dawley rats when the doses are below 480 mg/(kg·d) and no embryo-fatal toxicity when the doses are below 29 mg·/(kg·d). The results also indicate that Salvianolic acid B for injection has no genotoxic effect under the given conditions.
引文
[1]国家药典委员会.中国药典(一部)[M].北京:中国医药科技出版社,2015:24.
[2]ZHANG Y,TERUAKI A,NAKAMURA N,et al.Extremely low bioavailability of magnesium lithospermate B,an active component from Salvia miltiorrhiza,in rat[J].Planta medica,2004,70(2):138-142.
[3]ZHOU L M,CHOW M S,ZUO Z,et al.Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B[J].International journal of pharmaceutics,2009,379(1):109-118.
[4]武骏,徐立,许立.丹酚酸B对兔离体心脏缺氧再复氧损伤的保护作用[J].中国药理学与毒理学杂志,2007,21(3):212-216.
[5]臧慧梅,苏磊,陈家政,等.丹酚酸B通过PPARα抑制2型糖尿病小鼠心肌肥厚[J].中国药理学通报,2018,34(1):97-102.
[6]王晓玲,刘平,胡旭东,等.丹酚酸B抑制CCl4诱导大鼠肝纤维化形成的基因表达谱分析[J].上海中医药大学学报,2007,21(2):50-53.
[7]余晓云,陈婕,侯晓华.丹酚酸B的抗氧化作用对胰腺纤维化形成的影响[J].中华消化杂志,2007,27(6):409-410.
[8]蔡洲,李道,吴际,等.丹酚酸B对肾间质纤维化大鼠的肾保护作用及其机制[J].山东医药,2017,57(20):34-37.
[9]王新宇,王曼,孙帅军,等.丹酚酸B保护大鼠缺血心肌与炎症小体NLRP3表达的相关性研究[J].中国药理学通报,2016,32(10):1383-1388.
[10]马滢,方萌,伍超,等.丹酚酸B调控pSmad3C/pSmad3L发挥抗肝纤维化-肝细胞癌作用[J].中国药理学通报,2018,34(1):44-50.
[11]袁伯俊,廖明阳,李波.药物毒理学实验方法与技术[M].北京:化学工业出版社,2007:300-321.
[12]周莉,孙祖越.实验用兔和大鼠常见畸形图谱[M].上海:上海科学技术出版社,2015:139-286.
[13]桂玲,刘金玉,张程亮,等.丹参注射剂561例临床不良反应/事件分析[J].药物流行病学杂志,2017,26(8):547-550,564.
[14]林红.丹酚酸B对自发性糖尿病大鼠合并大血管病变的保护作用[J].中国药师,2016,19(5):836-838.